C Frank Bennett Ionis Pharmaceuticals Inc (IONS) insider trading activity

C Frank Bennett is EVP, Chief Scientific Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 79,607 shares of IONS, which is worth approximately $2.82 Million. The most recent transaction as insider was on Aug 30, 2024, when has been sold 177 shares (Common Stock) at a price of $38.64 per share, resulting in proceeds of $6,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.6K

0.18% 3M change

21.07% 12M change

Total Value Held $2.82 Million

C FRANK BENNETT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 30 2024	BUY Other acquisition or disposition	$6,839 $38.64 p/Share	177 Added 0.22%	79,607 Common Stock
Feb 29 2024	BUY Other acquisition or disposition	$13,182 $34.42 p/Share	383 Added 0.48%	79,462 Common Stock
Feb 02 2024	SELL Open market or private sale	$91,760 $49.52 p/Share	1,853 Reduced 2.29%	79,079 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	3,609 Added 4.27%	80,932 Common Stock
Jan 17 2024	SELL Open market or private sale	$340,082 $50.42 p/Share	6,745 Reduced 8.02%	77,323 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	18,314 Added 17.89%	84,068 Common Stock
Dec 21 2023	SELL Open market or private sale	$794,209 $49.29 p/Share	16,113 Reduced 19.68%	65,754 Common Stock
Dec 21 2023	BUY Exercise of conversion of derivative security	$762,789 $47.34 p/Share	16,113 Added 16.45%	81,867 Common Stock
Dec 20 2023	SELL Open market or private sale	$322,660 $49.64 p/Share	6,500 Reduced 9.0%	65,754 Common Stock
Dec 20 2023	BUY Exercise of conversion of derivative security	$307,710 $47.34 p/Share	6,500 Added 8.25%	72,254 Common Stock
Dec 14 2023	SELL Open market or private sale	$1,123,816 $49.7 p/Share	22,612 Reduced 25.59%	65,754 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$1,070,452 $47.34 p/Share	22,612 Added 23.32%	74,364 Common Stock
Sep 28 2023	SELL Open market or private sale	$207,390 $46.5 p/Share	4,460 Reduced 6.35%	65,754 Common Stock
Aug 31 2023	BUY Other acquisition or disposition	$5,500 $30.56 p/Share	180 Added 0.26%	70,214 Common Stock
Feb 28 2023	BUY Other acquisition or disposition	$11,689 $30.52 p/Share	383 Added 0.54%	70,034 Common Stock
Feb 06 2023	SELL Open market or private sale	$73,553 $40.57 p/Share	1,813 Reduced 2.54%	69,651 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	3,609 Added 4.81%	71,464 Common Stock
Jan 18 2023	SELL Open market or private sale	$271,374 $38.89 p/Share	6,978 Reduced 9.32%	67,855 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	19,417 Added 20.6%	74,833 Common Stock
Aug 31 2022	BUY Other acquisition or disposition	$5,302 $28.97 p/Share	183 Added 0.33%	55,416 Common Stock
Feb 28 2022	BUY Other acquisition or disposition	$9,816 $28.37 p/Share	346 Added 0.62%	55,233 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$202,587 $30.12 p/Share	6,726 Reduced 10.92%	54,887 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	18,842 Added 23.42%	61,613 Common Stock
Aug 31 2021	BUY Other acquisition or disposition	$5,104 $33.8 p/Share	151 Added 0.35%	42,771 Common Stock
Feb 26 2021	BUY Other acquisition or disposition	$4,988 $44.54 p/Share	112 Added 0.26%	42,620 Common Stock

CFB

C Frank Bennett

EVP, Chief Scientific Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account